2-(1-(tert-Butoxycarbonyl)azetidin-3-yl)-2-methylpropanoic acid, 98%, 500mg

(2R)-2-(FMOC-AMINO)-5-HEXYNOIC ACID, 95%, 250mg

Benzoyleneurea>98.0%(HPLC)(T)25g

Ethyl 2-(trans-4-aminocyclohexyl)acetate hydrochloride, 95.0%, 250mg

Diethyl acetylphosphonate, 96.0%, 5g

2-(2-Chloro-4-methylphenoxy)acetic acid, 97%, 25g

1-Bromo-2-fluoro-4-(2,2,2-trifluoroethoxy)benzene, 98%, 2.5g

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 10mg

3-(Methylamino)-4-nitrobenzoic acid, 95.0%, 250mg

5,7-Difluoroquinoline, 95.0%, 5g

Dimethyl 2,5-dibromoterephthalate, 95.0%, 25g

(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)(tert-butyl)dimethylsilane, 95%, 1g

5,6-Dimethylpyrazin-2-amine, 95.0%, 10g